Daly City, CA, United States of America

Martin A Apple


Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1977-1981

Loading Chart...
4 patents (USPTO):

Title: The Innovative Mind of Martin A Apple

Introduction

Martin A Apple is a notable inventor based in Daly City, California. With a total of four patents to his name, he has made significant contributions to the field of pharmaceuticals and biochemistry. His latest patents showcase innovative approaches to drug delivery and nucleic acid function inhibition, further establishing his legacy in the world of innovation.

Latest Patents

One of Martin A Apple’s most recent patents involves bis(4-demethoxydaunorubicin)dihydrazone derivatives. This invention includes a novel group of compounds that exhibit an enhanced capability to inhibit nucleic acid functions. These bis-anthracyclines, formed by linking two anthracycline molecules through their C-13 carbon atoms via amino and/or hydroxy-dicarboxylic acids, are designed for improved delivery to targeted sites within mammalian organisms by encapsulating them within uniformly sized liposomes.

Career Highlights

Martins A Apple has had an illustrious career, notably working at the University of California and at G.D. Searle & Company. His tenure at these institutions has allowed him to explore and develop groundbreaking pharmaceutical compounds that have the potential to impact health care positively. His research focuses on enhancing drug efficacy and delivery methods, making significant strides in medicinal chemistries.

Collaborations

Throughout his career, Martin has had the opportunity to collaborate with esteemed colleagues, including Joseph V Formica and C Anthony Hunt. These collaborations have likely contributed to the innovative approaches that define his patents, showcasing the power of teamwork in driving scientific advancements.

Conclusion

Martin A Apple exemplifies the spirit of innovation through his patents and collaborative efforts. As he continues to explore new horizons in drug development, his work remains vital not only to the scientific community but also to the broader field of medicine. His contributions will undoubtedly pave the way for future innovations in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…